{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:37:38Z","timestamp":1792791458792,"version":"4.5.0"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014355","name":"Nirma University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014355","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ijbiomac.2025.140789","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T02:53:32Z","timestamp":1738896812000},"page":"140789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"P1","title":["Unveiling the significance of synaptic proteins in parkinson's pathogenesis: A review"],"prefix":"10.1016","volume":"304","author":[{"given":"Ritu","family":"Soni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jigna","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.140789_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102208","article-title":"An update on new-age potential biomarkers for Parkinson\u2019s disease","volume":"94","author":"Soni","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0010","doi-asserted-by":"crossref","DOI":"10.1021\/acschemneuro.2c00165","article-title":"Deciphering intertwined molecular pathways underlying metabolic syndrome leading to Parkinson\u2019s disease","author":"Soni","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0015","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1021\/acschemneuro.3c00084","article-title":"Uncovering novel therapeutic targets for Parkinson\u2019s disease","volume":"14","author":"Soni","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0020","article-title":"Signaling pathways in Parkinson\u2019s disease: molecular mechanisms and therapeutic interventions","volume":"8","author":"Dong-Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0025","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1021\/acschemneuro.2c00165","article-title":"Deciphering intertwined molecular pathways underlying metabolic syndrome leading to Parkinson\u2019s disease","volume":"13","author":"Soni","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0030","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","article-title":"Alpha-synuclein: pathology, mitochondrial dysfunction and neuroinflammation in Parkinson\u2019s disease","volume":"109","author":"Rocha","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23042378","article-title":"Ferritinophagy and \u03b1-Synuclein: pharmacological targeting of autophagy to restore Iron regulation in Parkinson\u2019s disease","volume":"23","author":"Boag","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0040","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.neulet.2010.09.061","article-title":"Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo","volume":"486","author":"Chinta","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/S1353-8020(11)70065-7","article-title":"Neuroinflammation in Parkinson\u2019s disease","volume":"18","author":"Hirsch","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0050","first-page":"1","article-title":"The prion hypothesis in Parkinson\u2019s disease: Braak to the future","volume":"2","author":"Visanji","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/cells11111732","article-title":"Alpha-Synuclein aggregation pathway in Parkinson\u2019s disease: current status and novel therapeutic approaches","volume":"11","author":"Vidovi\u0107","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0060","article-title":"Alpha-Synuclein aggregation in Parkinson\u2019s disease","volume":"8","author":"Srinivasan","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109333","article-title":"Altered conformation of \u03b1-synuclein drives dysfunction of synaptic vesicles in a synaptosomal model of Parkinson\u2019s disease","volume":"36","author":"Fonseca-Ornelas","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21228645","article-title":"The role of \u03b1-synuclein oligomers in parkinson\u2019s disease","volume":"21","author":"Du","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20092338","article-title":"Identifying the pathological domain of alpha- synuclein as a therapeutic for parkinson\u2019s disease","volume":"20","author":"Shen","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2020.183251","article-title":"\u03b1-Synuclein fibrillation products trigger the release of hexokinase I from mitochondria: protection by curcumin, and possible role in pathogenesis of Parkinson\u2019s disease","volume":"1862","author":"Dehghani","year":"2020","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.578993","article-title":"Interaction of alpha-Synuclein with lipids: mitochondrial Cardiolipin as a critical player in the pathogenesis of Parkinson\u2019s disease","volume":"14","author":"Gilmozzi","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0090","doi-asserted-by":"crossref","unstructured":"J. Reyes, N. Rey, L. Bousset, R. Melki, P.B.- Glia, undefined 2014, Alpha-synuclein transfers from neurons to oligodendrocytes, Wiley Online Library (n.d.). doi:https:\/\/doi.org\/10.1002\/glia.22611 (accessed August 16, 2019).","DOI":"10.1002\/glia.22611"},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0095","unstructured":"C. Hansen, J.L.-T. In molecular medicine, undefined 2012, beyond \u03b1-synuclein transfer: pathology propagation in Parkinson's disease, Elsevier (n.d.). https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1471491412000366 (accessed August 16, 2019)."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0100","doi-asserted-by":"crossref","first-page":"11835","DOI":"10.1523\/JNEUROSCI.0983-17.2017","article-title":"Human astrocytes transfer aggregated alpha-synuclein via tunneling nanotubes","volume":"37","author":"Rostami","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0105","unstructured":"J. Steiner, E. Angot, P.B.-C. death and differentiation, undefined 2011, A deadly spread: cellular mechanisms of \u03b1-synuclein transfer, Nature.Com (n.d.). https:\/\/www.nature.com\/articles\/cdd201153 (accessed August 16, 2019)."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039465","article-title":"Alpha-Synuclein cell-to-cell transfer and seeding in grafted dopaminergic neurons in vivo","volume":"7","author":"Angot","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0115","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00401-013-1160-3","article-title":"Transfer of human \u03b1-synuclein from the olfactory bulb to interconnected brain regions in mice","volume":"126","author":"Rey","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713270","article-title":"The bidirectional interplay of \u03b1-Synuclein with lipids in the central nervous system and its implications for the pathogenesis of Parkinson\u2019s disease","volume":"24","author":"Battis","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.702639","article-title":"Alpha-Synuclein as a biomarker of Parkinson\u2019s disease: good, but not good enough","volume":"13","author":"Ganguly","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0130","first-page":"1883","article-title":"Baicalein inhibits \u03b1-synuclein oligomer formation and prevents progression of \u03b1-synuclein accumulation in a rotenone mouse model of Parkinson\u2019s disease","volume":"2016","author":"Hu","year":"1862","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0135","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-39480-z","article-title":"Cyclized NDGA modifies dynamic \u03b1-synuclein monomers preventing aggregation and toxicity","volume":"9","author":"Daniels","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0140","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-18349-z","article-title":"EGCG-mediated protection of the membrane disruption and cytotoxicity caused by the \u201cactive oligomer\u201d of \u03b1-Synuclein","volume":"7","author":"Yang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0145","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3390\/molecules26020415","article-title":"Beneficial effects of Epigallocatechin-3-O-Gallate, Chlorogenic acid, resveratrol, and curcumin on neurodegenerative diseases","volume":"26","author":"Fukutomi","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0150","doi-asserted-by":"crossref","first-page":"6834","DOI":"10.1007\/s12035-022-03005-z","article-title":"Chlorogenic acid: a polyphenol from coffee rendered neuroprotection against rotenone-induced Parkinson\u2019s disease by GLP-1 secretion","volume":"59","author":"Sharma","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0155","doi-asserted-by":"crossref","first-page":"9193","DOI":"10.1074\/jbc.M111.325548","article-title":"Curcumin prevents aggregation in \u03b1-synuclein by increasing reconfiguration rate","volume":"287","author":"Ahmad","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101902","article-title":"The small aromatic compound SynuClean-D inhibits the aggregation and seeded polymerization of multiple \u03b1-synuclein strains","volume":"298","author":"Pe\u00f1a-D\u00edaz","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0165","series-title":"Safety, Tolerability and Pharmacokinetics of the Oligomer Modulator anle138b with Exposure Levels Sufficient for Therapeutic Efficacy in a Murine Parkinson Model: A Randomised, Double-Blind, Placebo-Controlled Phase 1a Trial","author":"Levin","year":"2022"},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/biom12010142","article-title":"\u03b2-Synuclein: an enigmatic protein with diverse functionality","volume":"12","author":"Hayashi","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0175","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jnc.15134","article-title":"Dopamine promotes the neurodegenerative potential of \u03b2-synuclein","volume":"156","author":"Raina","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0180","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201800109","article-title":"Interactions between the intrinsically disordered proteins \u03b2-Synuclein and \u03b1-Synuclein","volume":"18","author":"Williams","year":"2018","journal-title":"Proteomics"},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0185","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1021\/acs.jproteome.9b00824","article-title":"Targeted mass spectrometry suggests Beta-Synuclein as synaptic blood marker in Alzheimer\u2019s disease","volume":"19","author":"Oeckl","year":"2020","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0190","first-page":"132","article-title":"New \u03b1- and \u03b3-synuclein immunopathological lesions in human brain","volume":"2","author":"Surgucheva","year":"2013","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0195","doi-asserted-by":"crossref","unstructured":"K. Nishioka, C. Vilari\u00f1 O-G\u00fcell, A.I. Soto-Ortolaza, S.J. Lincoln, J.M. Kachergus, B. Jasinska-Myga, O.A. Ross, A. Rajput, C.A. Robinson, T.J. Ferman, Z.K. Wszolek, D.W. Dickson, M.J. Farrer, Association of \u03b1- ,\u03b2-, \u03b3 and-Synuclein With Diffuse Lewy Body Disease, Arch. Neurol. 67 (2010) 970\u2013975. http:\/\/genome.ucsc.edu.","DOI":"10.1001\/archneurol.2010.177"},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0200","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0002-9440(10)64548-8","article-title":"Neurodegeneration with brain Iron accumulation, type 1 is characterized by \u03b1-, \u03b2-, and \u03b3-Synuclein neuropathology","volume":"157","author":"Galvin","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0205","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.1460-9568.2008.06055.x","article-title":"Increased striatal dopamine release and hyperdopaminergic-like behaviour in mice lacking both alpha-synuclein and gamma-synuclein","volume":"27","author":"Senior","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0210","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/j.1471-4159.2004.02378.x","article-title":"Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of \u03b3-synuclein, \u03b1-synuclein and double \u03b1\/\u03b3-synuclein null mutant mice","volume":"89","author":"Robertson","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0215","doi-asserted-by":"crossref","first-page":"11970","DOI":"10.1074\/jbc.M109541200","article-title":"Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of \u03b1-synuclein assembly by \u03b2- and \u03b3-synucleins","volume":"277","author":"Uversky","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0220","unstructured":"R. Kru, \u00c8. Ger, L. Scho, T. Mu, W. Kuhn, D. Woitalla, H. Przuntek, J.\u00c8. Rg, T. Epplen, O. Riess, Evaluation of the gamma-synuclein gene in German Parkinson's disease patients, n.d. www.elsevier.com\/locate\/neulet."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0225","unstructured":"Q.-X. Li, B.C. V Campbell, C.A. Mclean, D. Thyagarajan, W.-P. Gai, R.M. Kapsa, K. Beyreuther, C.L. Masters, J.G. Culvenor, Platelet \u03b1-and \u03b3-synucleins in Parkinson's disease and normal control subjects, 2002."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0230","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s003350010123","article-title":"Organization of the human synphilin-1 gene, a candidate for Parkinson\u2019s disease","volume":"11","author":"Engelender","year":"2000","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0235","author":"Liani"},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0240","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s00018-007-7343-0","article-title":"Synphilin-1 isoforms in Parkinson\u2019s disease: regulation by phosphorylation and ubiquitylation","volume":"65","author":"Szargel","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0245","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1046\/j.1471-4159.2001.00301.x","article-title":"Interaction of a-synuclein and synphilin-1: effect of Parkinson\u2019s disease-associated mutations","volume":"77","author":"Kawamata","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0282348","article-title":"Parkinsonian phenotypes induced by Synphilin-1 expression are differentially contributed by serotonergic and dopaminergic circuits and suppressed by nicotine treatment","volume":"18","author":"Carvajal-Oliveros","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0255","first-page":"1","article-title":"Synphilin-1 interacts with AMPK and increases AMPK phosphorylation","volume":"21","author":"Li","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22041677","article-title":"Yeasts as complementary model systems for the study of the pathological repercussions of enhanced synphilin-1 glycation and oxidation","volume":"22","author":"Seynnaeve","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0265","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neulet.2018.10.020","article-title":"Synphilin-1 has neuroprotective effects on MPP + -induced Parkinson\u2019s disease model cells by inhibiting ROS production and apoptosis","volume":"690","author":"Shishido","year":"2019","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0270","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00441-004-0953-z","article-title":"The role of synphilin-1 in synaptic function and protein degradation","volume":"318","author":"Kr\u00fcger","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0275","article-title":"Synphilin-1 as a modulator of aSyn assembly","author":"Gerhardt","year":"2023","journal-title":"Res Sq"},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0280","doi-asserted-by":"crossref","unstructured":"M.R. Wick, T.C. Allen, K.O. Leslie, J.H. Ritter, S.E. Mills, Neuroendocrine Lesions of the Lung, in: Practical Pulmonary Pathology: A Diagnostic Approach, Elsevier, 2011: pp. 409\u2013443. doi:https:\/\/doi.org\/10.1016\/B978-1-4160-5770-3.00027-4.","DOI":"10.1016\/B978-1-4160-5770-3.00027-4"},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0285","series-title":"Synaptophysin and Chromogranin a Immunoreactivities of Lewy Bodies in Parkinson\u2019s Disease Brains","author":"Nishimura","year":"1994"},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0290","first-page":"185","article-title":"Expression of synaptophysin protein in different dopaminergic cell lines","volume":"2","author":"Bai","year":"2014","journal-title":"J Biochem Pharmacol Res"},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0295","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/mds.26635","article-title":"Protein biomarkers in Parkinson\u2019s disease: focus on cerebrospinal fluid markers and synaptic proteins","volume":"31","author":"Halbgebauer","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0300","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/tra.12140","article-title":"The sybtraps: control of synaptobrevin traffic by synaptophysin, \u03b1-synuclein and AP-180","volume":"15","author":"Gordon","year":"2014","journal-title":"Traffic"},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0305","series-title":"Subcellular Localization of Wild-Type and Parkinson\u2019s Disease-Associated Mutant-Synuclein in Human and Transgenic Mouse Brain","author":"Kahle","year":"2000"},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0310","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.neuint.2018.10.015","article-title":"Docosahexaenoic acid protection in a rotenone induced Parkinson\u2019s model: prevention of tubulin and synaptophysin loss, but no association with mitochondrial function","volume":"121","author":"Serrano-Garc\u00eda","year":"2018","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0315","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.nbd.2005.01.014","article-title":"Synaptophysin enhances the neuroprotection of VMAT2 in MPP +-induced toxicity in MN9D cells","volume":"19","author":"Chen","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0320","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25112502","article-title":"Propionic acid and fasudil as treatment against rotenone toxicity in an in vitro model of Parkinson\u2019s disease","volume":"25","author":"Ostendorf","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0325","article-title":"Focused ultrasound promotes the delivery of Gastrodin and enhances the protective effect on dopaminergic neurons in a mouse model of Parkinson\u2019s disease","volume":"16","author":"Wang","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0330","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-020-00983-w","article-title":"Erythrocytic \u03b1-synuclein contained in microvesicles regulates astrocytic glutamate homeostasis: a new perspective on Parkinson\u2019s disease pathogenesis","volume":"8","author":"Sheng","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0335","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/jnnp.64.5.653","article-title":"Frontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer\u2019s disease and dementia","volume":"64","author":"Hansen","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0340","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.toxlet.2005.08.010","article-title":"Polychlorinated biphenyls alter expression of \u03b1-synuclein, synaptophysin and parkin in the rat brain","volume":"161","author":"Malkiewicz","year":"2006","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0345","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/jnc.15499","article-title":"Synaptophysin-dependent synaptobrevin-2 trafficking at the presynapse-mechanism and function","volume":"159","author":"Cousin","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0350","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.mito.2020.08.003","article-title":"Mitochondrial abnormalities in neurodegenerative models and possible interventions: focus on Alzheimer\u2019s disease, Parkinson\u2019s disease, Huntington\u2019s disease","volume":"55","author":"Pantiya","year":"2020","journal-title":"Mitochondrion"},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0355","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2886","article-title":"In vivo overexpression of synaptogyrin-3 promotes striatal synaptic dopamine uptake in LRRK2R1441G mutant mouse model of Parkinson\u2019s disease","volume":"13","author":"Ho","year":"2023","journal-title":"Brain Behav."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0360","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1523\/JNEUROSCI.4559-08.2009","article-title":"Physical and functional interaction between the dopamine transporter and the synaptic vesicle protein synaptogyrin-3","volume":"29","author":"Ega\u00f1a","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0365","article-title":"Transcriptional regulation of the synaptic vesicle protein Synaptogyrin-3 (SYNGR3) gene: the effects of NURR1 on its expression","volume":"23","author":"Li","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0370","article-title":"Identification of hub genes and potential molecular pathogenesis in substantia Nigra in Parkinson\u2019s disease via bioinformatics analysis","volume":"2023","author":"Zhou","year":"2023","journal-title":"Parkinsons Dis"},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0375","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.neuron.2018.01.022","article-title":"Synaptogyrin-3 mediates presynaptic dysfunction induced by tau","volume":"97","author":"McInnes","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0380","doi-asserted-by":"crossref","unstructured":"R. Janz, T.C. S\u00fc Dhof, R.E. Hammer, V. Unni, S.A. Siegelbaum, V.Y. Bolshakov, Essential Roles in Synaptic Plasticity for Synaptogyrin I and Synaptophysin I they Are Phosphorylated by an Endogenous Src-like Tyro-Sine Kinase on Synaptic Vesicles (Barnekow Et al Indicates that Synaptophysin I and Synaptogyrin I Are Physiological Substrates for Togyrin I and Bred Double Knockout Mice Deficient in, 1999.","DOI":"10.1016\/S0896-6273(00)81122-8"},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0385","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.conb.2020.04.006","article-title":"The diversity of synaptotagmin isoforms","volume":"63","author":"Wolfes","year":"2020","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0390","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1101\/gad.320077.118","article-title":"Synaptotagmin-11 mediates a vesicle trafficking pathway that is essential for development and synaptic plasticity","volume":"33","author":"Shimojo","year":"2019","journal-title":"Genes Dev."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0395","article-title":"Synaptotagmin-11 is a critical mediator of parkin-linked neurotoxicity and Parkinson\u2019s disease-like pathology","volume":"9","author":"Wang","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0400","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jns.2016.02.014","article-title":"Synaptotagmin XI in Parkinson\u2019s disease: new evidence from an association study in Spain and Mexico","volume":"362","author":"Sesar","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0405","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/glia.23186","article-title":"Synaptotagmin-11 inhibits cytokine secretion and phagocytosis in microglia","volume":"65","author":"Du","year":"2017","journal-title":"Glia"},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0410","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1002\/cne.23296","article-title":"Selective coexpression of synaptic proteins, \u03b1-synuclein, cysteine string protein-\u03b1, synaptophysin, synaptotagmin-1, and synaptobrevin-2 in vesicular acetylcholine transporter-immunoreactive axons in the guinea pig ileum","volume":"521","author":"Sharrad","year":"2013","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0415","doi-asserted-by":"crossref","unstructured":"V.D. J, M. Somayaji, N. Wade, B. Y\u00fccel, H. Zhao, J. Ribaudo, J. Gupta, T.T. Lam, D. Sames, D.L. Sulzer, S.S. Chandra, W.M. Keck, Dopamine transporter and synaptic vesicle sorting defects initiate auxilin-linked Parkinson's disease * Corresponding Author, (2022). doi:https:\/\/doi.org\/10.1101\/2022.02.04.479203.","DOI":"10.1101\/2022.02.04.479203"},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0420","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158586","article-title":"Increased expression of alpha-, Beta-, and gamma-Synucleins in brainstem regions of a non-human primate model of Parkinson\u2019s disease","volume":"23","author":"Duperrier","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0425","doi-asserted-by":"crossref","DOI":"10.1002\/alz.044515","article-title":"Cerebrospinal fluid levels of SNAP-25 and SYT1 in Alzheimer\u2019s and Parkinson\u2019s disease","volume":"16","author":"Brinkmalm","year":"2020","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0430","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.573696","article-title":"Alpha Synuclein connects the gut-brain Axis in Parkinson\u2019s disease patients \u2013 a view on clinical aspects, cellular pathology and analytical methodology","volume":"8","author":"Schaeffer","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0435","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10571-021-01066-7","article-title":"The gut-brain Axis: two ways signaling in Parkinson\u2019s disease","volume":"42","author":"Dogra","year":"2022","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.ijbiomac.2025.140789_bb0440","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158586","article-title":"Increased expression of alpha-, Beta-, and gamma-Synucleins in brainstem regions of a non-human primate model of Parkinson\u2019s disease","volume":"23","author":"Duperrier","year":"2022","journal-title":"Int. J. Mol. Sci."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025013388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025013388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T04:07:45Z","timestamp":1776571665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025013388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":88,"alternative-id":["S0141813025013388"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.140789","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unveiling the significance of synaptic proteins in parkinson's pathogenesis: A review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.140789","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"140789"}}